Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine

H Chaytow, KME Faller, YT Huang… - Cell Reports Medicine, 2021 - cell.com
Spinal muscular atrophy (SMA) is a devastating childhood motor neuron disease that, in the
most severe cases and when left untreated, leads to death within the first two years of life …

Inhibition of RNA-binding proteins with small molecules

P Wu - Nature Reviews Chemistry, 2020 - nature.com
Protein–RNA interactions have crucial roles in various cellular activities, which, when
dysregulated, can lead to a range of human diseases. The identification of small molecules …

[HTML][HTML] Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls

BT Darras, R Masson… - … England Journal of …, 2021 - Mass Medical Soc
Background Type 1 spinal muscular atrophy (SMA) is a progressive neuromuscular disease
characterized by an onset at 6 months of age or younger, an inability to sit without support …

New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?

TH Chen - International journal of molecular sciences, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is a congenital neuromuscular disorder characterized by
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …

Spinal muscular atrophy

S Nicolau, MA Waldrop, AM Connolly… - Seminars in pediatric …, 2021 - Elsevier
Spinal muscular atrophy is one of the most common neuromuscular disorders of childhood
and has high morbidity and mortality. Three different disease-modifying treatments were …

Overturning the paradigm of spinal muscular atrophy as just a motor neuron disease

CJJ Yeo, BT Darras - Pediatric neurology, 2020 - Elsevier
Spinal muscular atrophy is typically characterized as a motor neuron disease. Untreated
patients with the most severe form, spinal muscular atrophy type 1, die early with infantile …

New approaches to target RNA binding proteins

AR Julio, KM Backus - Current opinion in chemical biology, 2021 - Elsevier
RNA binding proteins (RBPs) are a large and diverse class of proteins that regulate all
aspects of RNA biology. As RBP dysregulation has been implicated in a number of human …

Therapeutic advances for Huntington's disease

A Kumar, V Kumar, K Singh, S Kumar, YS Kim, YM Lee… - Brain sciences, 2020 - mdpi.com
Huntington's disease (HD) is a progressive neurological disease that is inherited in an
autosomal fashion. The cause of disease pathology is an expansion of cytosine-adenine …

Alternative splicing and related RNA binding proteins in human health and disease

Y Tao, Q Zhang, H Wang, X Yang, H Mu - Signal Transduction and …, 2024 - nature.com
Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation,
engendering transcript diversity, and modifications in protein structure and functionality …

[HTML][HTML] Targeting non-coding RNAs: Perspectives and challenges of in-silico approaches

R Rocca, K Grillone, EL Citriniti, G Gualtieri… - European Journal of …, 2023 - Elsevier
The growing information currently available on the central role of non-coding RNAs
(ncRNAs) including microRNAs (miRNAS) and long non-coding RNAs (lncRNAs) for chronic …